SUVEN PHARMACEUTICALS
|
SUVEN PHARMACEUTICALS Last 5 Year Income Statement History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
INCOME : | |||||
Gross Sales | ₹1,051 Cr | ₹134,149 Cr | ₹1,321 Cr | ₹1,010 Cr | ₹834 Cr |
Sales | ₹1,024 Cr | ₹128,601 Cr | ₹1,254 Cr | ₹949 Cr | ₹774 Cr |
Job Work/ Contract Receipts | - | - | - | - | - |
Processing Charges / Service Income | ₹9.94 Cr | ₹4,626 Cr | ₹54 Cr | ₹46 Cr | ₹44 Cr |
Revenue from property development | - | - | - | - | - |
Other Operational Income | ₹17 Cr | ₹922 Cr | ₹13 Cr | ₹14 Cr | ₹17 Cr |
Less: Excise Duty | - | - | - | - | - |
Net Sales | ₹1,051 Cr | ₹134,033 Cr | ₹1,320 Cr | ₹1,010 Cr | ₹834 Cr |
EXPENDITURE : | |||||
Increase/Decrease in Stock | ₹49 Cr | ₹-2,094 Cr | ₹-60 Cr | ₹-8.37 Cr | ₹-11 Cr |
Raw Material Consumed | ₹263 Cr | ₹42,391 Cr | ₹454 Cr | ₹306 Cr | ₹236 Cr |
Opening Raw Materials | ₹77 Cr | ₹7,290 Cr | ₹51 Cr | ₹35 Cr | ₹30 Cr |
Purchases Raw Materials | ₹231 Cr | ₹42,845 Cr | ₹475 Cr | ₹323 Cr | ₹241 Cr |
Closing Raw Materials | ₹46 Cr | ₹7,744 Cr | ₹72 Cr | ₹51 Cr | ₹35 Cr |
Other Direct Purchases / Brought in cost | - | - | - | - | - |
Other raw material cost | - | - | - | - | - |
Power & Fuel Cost | ₹48 Cr | ₹7,393 Cr | ₹60 Cr | ₹44 Cr | ₹38 Cr |
Electricity & Power | ₹48 Cr | ₹7,393 Cr | ₹60 Cr | ₹44 Cr | ₹38 Cr |
Oil, Fuel & Natural gas | - | - | - | - | - |
Coals etc | - | - | - | - | - |
Other power & fuel | - | - | - | - | - |
Employee Cost | ₹135 Cr | ₹11,825 Cr | ₹100 Cr | ₹76 Cr | ₹65 Cr |
Salaries, Wages & Bonus | ₹120 Cr | ₹10,671 Cr | ₹91 Cr | ₹68 Cr | ₹58 Cr |
Contributions to EPF & Pension Funds | ₹7.36 Cr | ₹617 Cr | ₹5.21 Cr | ₹4.18 Cr | ₹3.35 Cr |
Workmen and Staff Welfare Expenses | ₹3.35 Cr | ₹315 Cr | ₹2.52 Cr | ₹2.42 Cr | ₹2.57 Cr |
Other Employees Cost | ₹4.43 Cr | ₹222 Cr | ₹2.21 Cr | ₹1.86 Cr | ₹1.52 Cr |
Other Manufacturing Expenses | ₹88 Cr | ₹10,962 Cr | ₹129 Cr | ₹105 Cr | ₹84 Cr |
Sub-contracted / Out sourced services | - | - | - | - | - |
Processing Charges | - | - | - | - | - |
Repairs and Maintenance | ₹57 Cr | ₹1,708 Cr | ₹22 Cr | ₹20 Cr | ₹15 Cr |
Packing Material Consumed | ₹3.18 Cr | ₹617 Cr | ₹5.05 Cr | ₹4.38 Cr | ₹3.87 Cr |
Other Mfg Exp | ₹29 Cr | ₹8,637 Cr | ₹102 Cr | ₹81 Cr | ₹65 Cr |
General and Administration Expenses | ₹27 Cr | ₹3,387 Cr | ₹29 Cr | ₹28 Cr | ₹26 Cr |
Rent , Rates & Taxes | ₹1.67 Cr | ₹46 Cr | ₹0.33 Cr | ₹1.28 Cr | ₹2.51 Cr |
Insurance | ₹11 Cr | ₹886 Cr | ₹7.11 Cr | ₹7.23 Cr | ₹5.99 Cr |
Printing and stationery | - | ₹76 Cr | ₹0.36 Cr | ₹0.36 Cr | ₹0.44 Cr |
Professional and legal fees | ₹4.12 Cr | ₹544 Cr | ₹4.09 Cr | ₹4.38 Cr | ₹2.53 Cr |
Traveling and conveyance | ₹9.37 Cr | ₹857 Cr | ₹6.87 Cr | ₹6.40 Cr | ₹6.18 Cr |
Other Administration | ₹1.29 Cr | ₹979 Cr | ₹10 Cr | ₹8.08 Cr | ₹8.33 Cr |
Selling and Distribution Expenses | ₹10 Cr | ₹1,764 Cr | ₹20 Cr | ₹11 Cr | ₹9.43 Cr |
Advertisement & Sales Promotion | ₹3.48 Cr | ₹349 Cr | ₹1.88 Cr | ₹1.84 Cr | ₹3.60 Cr |
Sales Commissions & Incentives | ₹1.99 Cr | ₹138 Cr | ₹1.59 Cr | ₹1.62 Cr | ₹2.04 Cr |
Freight and Forwarding | - | ₹1,276 Cr | ₹16 Cr | ₹7.07 Cr | ₹3.79 Cr |
Handling and Clearing Charges | ₹4.99 Cr | - | - | - | - |
Other Selling Expenses | - | - | - | - | - |
Miscellaneous Expenses | ₹24 Cr | ₹990 Cr | ₹6.37 Cr | ₹5.16 Cr | ₹1.08 Cr |
Bad debts /advances written off | - | - | - | - | - |
Provision for doubtful debts | - | - | - | - | - |
Losson disposal of fixed assets(net) | ₹0.07 Cr | ₹0.65 Cr | ₹0.20 Cr | - | ₹0.02 Cr |
Losson foreign exchange fluctuations | - | - | - | - | - |
Losson sale of non-trade current investments | - | - | - | - | - |
Other Miscellaneous Expenses | ₹24 Cr | ₹989 Cr | ₹6.17 Cr | ₹5.16 Cr | ₹1.06 Cr |
Less: Expenses Capitalised | - | - | - | - | - |
Total Expenditure | ₹646 Cr | ₹76,617 Cr | ₹739 Cr | ₹567 Cr | ₹449 Cr |
Operating Profit (Excl OI) | ₹406 Cr | ₹57,416 Cr | ₹582 Cr | ₹443 Cr | ₹385 Cr |
Other Income | ₹62 Cr | ₹4,636 Cr | ₹92 Cr | ₹14 Cr | ₹18 Cr |
Interest Received | ₹1.93 Cr | ₹583 Cr | ₹0.07 Cr | ₹0.27 Cr | ₹0.36 Cr |
Dividend Received | - | - | - | - | - |
Profit on sale of Fixed Assets | - | - | ₹0.00 Cr | ₹0.03 Cr | ₹0.08 Cr |
Profits on sale of Investments | - | ₹1,569 Cr | ₹74 Cr | ₹3.33 Cr | ₹6.23 Cr |
Provision Written Back | ₹0.27 Cr | ₹12 Cr | ₹0.37 Cr | - | ₹0.15 Cr |
Foreign Exchange Gains | ₹8.12 Cr | ₹2,144 Cr | ₹16 Cr | ₹9.56 Cr | ₹11 Cr |
Others | ₹52 Cr | ₹329 Cr | ₹1.10 Cr | ₹1.05 Cr | ₹0.26 Cr |
Operating Profit | ₹468 Cr | ₹62,053 Cr | ₹674 Cr | ₹457 Cr | ₹403 Cr |
Interest | ₹7.45 Cr | ₹1,281 Cr | ₹8.53 Cr | ₹12 Cr | ₹23 Cr |
InterestonDebenture / Bonds | - | - | - | - | - |
Interest on Term Loan | ₹2.87 Cr | ₹530 Cr | ₹5.92 Cr | ₹8.68 Cr | ₹17 Cr |
Intereston Fixed deposits | - | - | - | - | - |
Bank Charges etc | ₹3.34 Cr | ₹737 Cr | ₹2.30 Cr | ₹2.52 Cr | ₹3.15 Cr |
Other Interest | ₹1.24 Cr | ₹14 Cr | ₹0.31 Cr | ₹0.47 Cr | ₹2.79 Cr |
PBDT | ₹460 Cr | ₹60,772 Cr | ₹666 Cr | ₹446 Cr | ₹380 Cr |
Depreciation | ₹55 Cr | ₹4,799 Cr | ₹39 Cr | ₹32 Cr | ₹24 Cr |
Profit Before Taxation & Exceptional Items | ₹406 Cr | ₹55,973 Cr | ₹626 Cr | ₹414 Cr | ₹356 Cr |
Exceptional Income / Expenses | - | - | - | - | - |
Profit Before Tax | ₹406 Cr | ₹55,973 Cr | ₹668 Cr | ₹468 Cr | ₹405 Cr |
Provision for Tax | ₹105 Cr | ₹14,844 Cr | ₹214 Cr | ₹105 Cr | ₹88 Cr |
Current Income Tax | ₹100 Cr | ₹14,627 Cr | ₹190 Cr | ₹102 Cr | ₹89 Cr |
Deferred Tax | ₹6.59 Cr | ₹434 Cr | ₹23 Cr | ₹3.62 Cr | ₹-1.30 Cr |
Other taxes | ₹-0.78 Cr | ₹-217 Cr | - | ₹0.18 Cr | - |
Profit After Tax | ₹300 Cr | ₹41,129 Cr | ₹454 Cr | ₹362 Cr | ₹317 Cr |
Extra items | - | - | - | - | - |
Minority Interest | - | - | - | - | - |
Share of Associate | - | - | - | - | - |
Other Consolidated Items | - | - | - | - | - |
Consolidated Net Profit | ₹300 Cr | ₹41,129 Cr | ₹454 Cr | ₹362 Cr | ₹317 Cr |
Adjustments to PAT | - | - | - | - | - |
Profit Balance B/F | ₹1,465 Cr | ₹127,271 Cr | ₹936 Cr | ₹615 Cr | ₹391 Cr |
Appropriations | ₹1,765 Cr | ₹168,400 Cr | ₹1,390 Cr | ₹978 Cr | ₹708 Cr |
General Reserves | - | ₹1,500 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Corporate dividend tax | - | - | - | - | ₹13 Cr |
Other Appropriation | ₹0.32 Cr | ₹5,110 Cr | ₹26 Cr | ₹0.84 Cr | ₹0.82 Cr |
Equity Dividend % | - | ₹600.00 | ₹500.00 | ₹200.00 | ₹500.00 |
Earnings Per Share | ₹11.79 | ₹16.16 | ₹17.83 | ₹14.23 | ₹24.91 |
Adjusted EPS | ₹11.79 | ₹16.16 | ₹17.83 | ₹14.23 | ₹12.45 |
Compare Income Statement of peers of SUVEN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUVEN PHARMACEUTICALS | ₹34,975.4 Cr | -6.9% | -0.7% | -17.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹395,626.0 Cr | 2% | 1.4% | -13% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,996.0 Cr | 1.3% | 0.3% | 10.4% | Stock Analytics | |
CIPLA | ₹127,494.0 Cr | 0.3% | 1.9% | -6.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,718.0 Cr | 0% | -2.3% | 2.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,374.0 Cr | 0.5% | 6.2% | -1.4% | Stock Analytics |
SUVEN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUVEN PHARMACEUTICALS | -6.9% |
-0.7% |
-17.4% |
SENSEX | 1.8% |
2.1% |
0.2% |
You may also like the below Video Courses